Cue Health, the once high-flying San Digeo biotech supplying rapid COVID-19 test kits to the NBA and others, is shutting down this week. Cue’s closure comes a week after the U.S. Food and Drug Administration warned consumers to throw out any of its COVID-19 test kits because they could give false results. The San Diego firm said it has stopped selling the COVID-19 tests, which was its only fully FDA-approved commercial product.
The biotech grew its headcount from 99 employees in January 2020 to 1,515 full-time employees at the end of 2022. The company, which was founded in 2010, soared into the public market with a $200 million IPO in 2021, fueled by its first commercial product, the COVID-19 test. Its sleek, high-tech kit delivered results in 15 minutes straight to a smartphone and was one of the first to get fast-track approval from the FDA during the pandemic.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: sdut - 🏆 5. / 95 Read more »